<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-31T07:32:16+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>FDA批准药物的全景分析（二）：复杂制剂及制剂未来</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/J0EhjNacmqNwfq0iS0opRA</id>
    <link href="https://mp.weixin.qq.com/s/J0EhjNacmqNwfq0iS0opRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA批准和记黄埔的索凡替尼用于神经内分泌瘤治疗</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/Mu356o9k4faGSxss_20iwA</id>
    <link href="https://mp.weixin.qq.com/s/Mu356o9k4faGSxss_20iwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药三大局势已定，不知道的白混了~</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/9HGKbltxYK9_ueSPmD2p_A</id>
    <link href="https://mp.weixin.qq.com/s/9HGKbltxYK9_ueSPmD2p_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判，哪些抗肿瘤药纳入医保？（附名单）</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/09_V2CsALWrxqHL-sJjVGA</id>
    <link href="https://mp.weixin.qq.com/s/09_V2CsALWrxqHL-sJjVGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准药物的全景分析：药物概况、给药途径和剂型分布（一）</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/RLAHelxlfZzTsab3oYAmig</id>
    <link href="https://mp.weixin.qq.com/s/RLAHelxlfZzTsab3oYAmig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药的盛宴（医保谈判结果简评，附谈判降幅排名）</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/wDTMDjc538bYabSFwSM_ng</id>
    <link href="https://mp.weixin.qq.com/s/wDTMDjc538bYabSFwSM_ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杂质检测方法精密度与耐用性验证是否需要加标？</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/AZVkx_NfBznqifoq9OZrOw</id>
    <link href="https://mp.weixin.qq.com/s/AZVkx_NfBznqifoq9OZrOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三医联动新消息：事关精神心理疾病的医疗保障、药品“带量采购”</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/JBYFi6mizqYnPav3NP2KUQ</id>
    <link href="https://mp.weixin.qq.com/s/JBYFi6mizqYnPav3NP2KUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>韩国特应性皮炎新药寻求中国合作伙伴</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/fVWesQ52wRryK9ySX_d4qA</id>
    <link href="https://mp.weixin.qq.com/s/fVWesQ52wRryK9ySX_d4qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020版医保目录发布：119个品种谈判成功，评均降价50.64%</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/H7-tOTmVjqSwoi-rlQjAjw</id>
    <link href="https://mp.weixin.qq.com/s/H7-tOTmVjqSwoi-rlQjAjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>气相方法开发的要点和关键点</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/MmdJJSAm5IC_maBlO62fTg</id>
    <link href="https://mp.weixin.qq.com/s/MmdJJSAm5IC_maBlO62fTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年FDA批准的53个新药逐个评述</title>
    <updated>2020-12-27T23:09:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/yIWiahbH8lRrLWSkgMXJtg</id>
    <link href="https://mp.weixin.qq.com/s/yIWiahbH8lRrLWSkgMXJtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>原辅料粒径偏大？试一试气流粉碎</title>
    <updated>2020-12-27T23:09:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/O2iPB7puWlfHCPKqYcXIQg</id>
    <link href="https://mp.weixin.qq.com/s/O2iPB7puWlfHCPKqYcXIQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂工艺放大中物料混合的影响因素VS解决策略</title>
    <updated>2020-12-27T23:09:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/aC13d-oD9jcuBHwG7FI9Ew</id>
    <link href="https://mp.weixin.qq.com/s/aC13d-oD9jcuBHwG7FI9Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国家集采相关信息申报工作正式开始​</title>
    <updated>2020-12-26T22:00:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/hZHS7kckw2hGuObdRd13Fg</id>
    <link href="https://mp.weixin.qq.com/s/hZHS7kckw2hGuObdRd13Fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>北京诺诚健华的1类新药奥布替尼获批上市</title>
    <updated>2020-12-26T22:00:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/-9RAsFuhiPiNkqvHTpIo9w</id>
    <link href="https://mp.weixin.qq.com/s/-9RAsFuhiPiNkqvHTpIo9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药事纵横广告投放须知</title>
    <updated>2020-12-26T22:00:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/nIjKcw0GpT7kvg77-qyUQA</id>
    <link href="https://mp.weixin.qq.com/s/nIjKcw0GpT7kvg77-qyUQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA四季度批准的新药</title>
    <updated>2020-12-26T00:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/ZHVRPjfYj-fLzbmI7E5dkg</id>
    <link href="https://mp.weixin.qq.com/s/ZHVRPjfYj-fLzbmI7E5dkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药事纵横投稿须知：稿费已上调，欢迎投稿</title>
    <updated>2020-12-26T00:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/nN5xN50zc_ACqedf9UpAEQ</id>
    <link href="https://mp.weixin.qq.com/s/nN5xN50zc_ACqedf9UpAEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>紫杉烷类药物，改良型药物发展之路</title>
    <updated>2020-12-24T17:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/Cy_vfz_3sboMm7zSupXyGQ</id>
    <link href="https://mp.weixin.qq.com/s/Cy_vfz_3sboMm7zSupXyGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>